Lipid Nanoparticle MRNA Therapy Improves Survival in Mouse Models of Maple Syrup Urine Disease
August 22, 2024
August 22, 2024
NEW ROCHELLE, New York, Aug. 22 (TNSres) -- Mary Ann Liebert Inc. issued the following news release:
Researchers from the University of Pennsylvania, Perelman School of Medicine, Gene Therapy Program, and Moderna, have shown that repeated administration of lipid nanoparticle-encapsulated mRNA therapy significantly extended survival and reduced serum leucine levels in a mouse model of maple syrup urine disease (MSUD). Click here [View article in the link at bottom.] to read the artic . . .
Researchers from the University of Pennsylvania, Perelman School of Medicine, Gene Therapy Program, and Moderna, have shown that repeated administration of lipid nanoparticle-encapsulated mRNA therapy significantly extended survival and reduced serum leucine levels in a mouse model of maple syrup urine disease (MSUD). Click here [View article in the link at bottom.] to read the artic . . .